Caligan Partners LP 13D/13G Filings for LB Pharmaceuticals Inc Common Stock (LBRX)

Caligan Partners LP 13D and 13G filings for LB Pharmaceuticals Inc Common Stock:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-05-15
10:43 am
Purchase
2026-03-3113GLB PHARMACEUTICALS INC
LBRX
Caligan Partners LP1,438,070
5.000%
1,438,070increase
(New Position)
Filing